Lilly's Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)

Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 BRUIN CLL-314 clinical trial evaluating Jaypirca ...

5 Liver health myths you should stop believing

The liver functions continuously to eliminate toxins while aiding digestion and storing energy, but various false liver ...
equitymaster.com

LOGICIEL SOLUTIONS LTD. News & Analysis

ALPHALOGIC INDUSTRIES: Get the latest ALPHALOGIC INDUSTRIES Share price and stock price updates, live NSE/BSE share price, share market reports, financial report, balance sheet, price charts, ...
India Water Portal

FAQ: Everything you need to know about the blue economy

Deep dive into the challenges and opportunities of India's Blue Economy. Learn about the Deep Ocean Mission, the risks of ...